Japan Market Explorer
JPX Innovation
C
Consumer Discretionary / Specialty Retail

Sales / Return on Equity

Sales
+0.03%
¥ 14.19B
Last 12 Months
Return on Equity
+0.18%
-5.27
Last 12 Months

Gross Profit / Operating Income / Net Income

Operating Income
+0.02%
¥ -1.03B
Last 12 Months
Net Income
+0.16%
¥ -530.0M
Last 12 Months

Corporate Events

14 items

2025-06-13

Buyback Transaction Closings

CROOZ, Inc.'s Equity Buyback announced on February 13, 2024, has expired.

The company expired its plan on February 13, 2025.

2025-05-22

M&A Transaction Closings

HADO Inc. acquired Rank King, Inc. from CROOZ, Inc. (TSE:2138).

HADO Inc. acquired Rank King, Inc. from CROOZ, Inc. (TSE:2138) on March 2025. HADO Inc. completed the acquisition of Rank King, Inc. from CROOZ, Inc. (TSE:2138) on March 2025.

2025-05-15

M&A Transaction Announcements

Boat LLC agreed to acquire StudioZ Inc from CROOZ, Inc. (TSE:2138) for ¥200 million.

Boat LLC agreed to acquire StudioZ Inc from CROOZ, Inc. (TSE:2138) for ¥200 million on May 14, 2025. As part of consideration, ¥200 million is paid towards 12,000 common equity of StudioZ Inc. The expected completion of the transaction is June 2, 2025.

2025-05-14

Annual General Meeting

CROOZ, Inc., Annual General Meeting, Jun 27, 2025

CROOZ, Inc., Annual General Meeting, Jun 27, 2025.

2025-04-05

Earnings Release Date

CROOZ, Inc. to Report Fiscal Year 2025 Results on May 14, 2025

CROOZ, Inc. announced that they will report fiscal year 2025 results on May 14, 2025

2025-03-04

M&A Transaction Closings

MEDIQUITOUS Co., Ltd. completed the acquisition of CROOZ SHOPLIST Co., Ltd. from CROOZ, Inc. (TSE:2138) for approximately ¥830 million.

MEDIQUITOUS Co., Ltd. agreed to acquire CROOZ SHOPLIST Co., Ltd. from CROOZ, Inc. (TSE:2138) on January 17, 2025. For the period ending March 31, 2024, CROOZ SHOPLIST Co., Ltd. reported total revenue of ¥6.85 billion, EBIT of ¥196 million and net income of ¥109 million. As of March 31, 2024, CROOZ SHOPLIST Co., Ltd. reported total assets of ¥4.16 billion and total common equity of ¥1.55 billion. The expected completion of the transaction is February 28, 2025. MEDIQUITOUS Co., Ltd. completed the acquisition of CROOZ SHOPLIST Co., Ltd. from CROOZ, Inc. (TSE:2138) for approximately ¥830 million on February 28, 2025.

2025-02-06

Earnings Release Date

CROOZ, Inc. to Report Q3, 2025 Results on Feb 12, 2025

CROOZ, Inc. announced that they will report Q3, 2025 results on Feb 12, 2025

2025-01-20

M&A Transaction Announcements

MEDIQUITOUS Co., Ltd. agreed to acquire CROOZ SHOPLIST Co., Ltd. from CROOZ, Inc. (TSE:2138).

MEDIQUITOUS Co., Ltd. agreed to acquire CROOZ SHOPLIST Co., Ltd. from CROOZ, Inc. (TSE:2138) on January 17, 2025. For the period ending March 31, 2024, CROOZ SHOPLIST Co., Ltd. reported total revenue of ¥6.85 billion, EBIT of ¥196 million and net income of ¥109 million. As of March 31, 2024, CROOZ SHOPLIST Co., Ltd. reported total assets of ¥4.16 billion and total common equity of ¥1.55 billion. The expected completion of the transaction is February 28, 2025.

2025-01-08

Buyback Tranche Update

Tranche Update on CROOZ, Inc. (TSE:2138)'s Equity Buyback Plan announced on February 13, 2024.

From October 1, 2024 to December 31, 2024, the company has repurchased 154,900 shares, representing 1.58% for ¥93.82 million. With this, the company has completed the repurchase of 1,487,100 shares, representing 14.05% for ¥1,148.67 million under the buyback announced on February 13, 2024.

2024-10-26

Earnings Release Date

CROOZ, Inc. to Report Q2, 2025 Results on Nov 13, 2024

CROOZ, Inc. announced that they will report Q2, 2025 results on Nov 13, 2024

2024-10-03

Buyback Tranche Update

Tranche Update on CROOZ, Inc. (TSE:2138)'s Equity Buyback Plan announced on February 13, 2024.

From July 1, 2024 to September 30, 2024, the company has repurchased 310,700 shares, representing 3.08% for ¥201.18 million. With this, the company has completed the repurchase of 1,332,200 shares, representing 12.46% for ¥1,054.85 million under the buyback announced on February 13, 2024.

2024-09-25

End of Lock-Up Period

Certain Shares of ROXX,inc. are subject to a Lock-Up Agreement Ending on 23-MAR-2025.

Certain Shares of ROXX,inc. are subject to a Lock-Up Agreement Ending on 23-MAR-2025. These Shares will be under lockup for 179 days starting from 25-SEP-2024 to 23-MAR-2025. Details: the shareholders has agreed for a lock-up of 1080,360 and 180 days after the listing date.

2024-09-25

IPOs

ROXX,inc. has completed an IPO in the amount of ¥6.167741 billion.

ROXX,inc. has completed an IPO in the amount of ¥6.167741 billion. Security Name: Common Stock Security Type: Common Stock Securities Offered: 325,000 Price\Range: ¥2110 Discount Per Security: ¥168.8 Security Name: Common Stock Security Type: Common Stock Securities Offered: 2,598,100 Price\Range: ¥2110 Discount Per Security: ¥168.8 Transaction Features: Sponsor Backed Offering

2024-08-19

IPOs

ROXX Inc. has filed an IPO.

ROXX Inc. has filed an IPO. Security Name: Shares Security Type: Common Stock Securities Offered: 325,000 Security Name: Shares Security Type: Common Stock Securities Offered: 2,598,100 Transaction Features: Sponsor Backed Offering

Financial Data

(Million JPY)
2025Q1
2024Q4
2024Q3
2024Q2
2024Q1
2023Q4
2023Q3
Total Revenues
14,191
14,518
14,336
14,381
14,270
13,788
13,834
Pretax Income Excl.Unusual Items
-837
-842
-946
403
1,226
1,262
1,979
Total Assets
29,530
31,031
30,072
26,552
27,084
28,075
28,266
Total Liabilities
20,205
21,274
20,257
16,219
16,277
16,470
16,797
Cash & Cash Equivalents
10,104
10,589
10,474
10,310
12,856
14,310
15,051
Total Common Equity
9,200
9,623
9,658
10,184
10,655
11,439
11,301
Book Value Per Share (BVPS)
961.57
998.73
986.5
1,008.23
1,018.53
1,028.46
1,016.06
Net Change in Cash
-2,752
-4,577
-1,450
868
Capital Expenditure
-59
-77
-34
-29

On June 30, 2025, CROOZ shared its financial results for the first quarter of 2025, having revenues of 3.23B yen and net loss of -38M yen, indicating a decline of 9.2% in revenue, along with a significant reduction in loss per share compared with the same quarter last year.

and it trades at 0.64 times price to book ratio, which is lower than the industry average (P/B 1.51).